ONO-4538 Phase III Study A Multicenter, Double-Blind, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer
ONO-4538 Phase III Study A Multicenter, Double-Blind, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer
The purpose of study is to evaluate the efficacy and safety of ONO-4538 in patients with unresectable advanced or recurrent gastric cancer (including esophagogastric junction cancer) refractory to or intolerant of standard therapy.
Inclusion Criteria:
Exclusion Criteria:
Kitaadachi, Saitama 362-0806, Japan
Sunto-gun, Shizuoka 411-8777, Japan
Bunkyo-ku, Tokyo 113-8677, Japan
Chuo-ku, Tokyo 104-0045, Japan
Koto-ku, Tokyo 135-8550, Japan
Shinjuku-ku, Tokyo 160-8582, Japan